Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sodium-glucose Cotransporter-2 Inhibitor”

45 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 45 results

Large-scale testing (Phase 3)UnknownNCT04860011
What this trial is testing

DAPAgliflozin Versus Thiazide Diuretic in Patients With Heart Failure and Diuretic RESISTance

Who this might be right for
Heart Failure
NHS Greater Glasgow and Clyde 61
Post-approval studies (Phase 4)Not Yet RecruitingNCT07240844
What this trial is testing

Enavogliflozin for the Management of Patients With Amyloid CardiomyopaThy

Who this might be right for
Amyloid Cardiomyopathy
Seoul St. Mary's Hospital 68
Large-scale testing (Phase 3)Enrolling By InvitationNCT07065357
What this trial is testing

Treating the Metabolic Syndrome With a Sodium-glucose Cotransporter-2 Inhibitor

Who this might be right for
Metabolic Syndrome
The University of Hong Kong 160
Not applicableStudy completedNCT05764811
What this trial is testing

SGLT-2 Inhibitor Effects on Cardiac and Hepatic Metabolic Profiles for the Diabetes Patients Combined With Obesity

Who this might be right for
Fatty Liver Disease
National Cheng-Kung University Hospital 40
Early research (Phase 1)Not Yet RecruitingNCT07172971
What this trial is testing

Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy

Who this might be right for
Duchenne Muscular Dystrophy (DMD)
Larry W. Markham 10
Post-approval studies (Phase 4)Study completedNCT05989503
What this trial is testing

Initiation of ARNi and SGLT2i in Patients With HFrEF

Who this might be right for
Heart Failure With Reduced Ejection Fraction
Universidade do Porto 62
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06655480
What this trial is testing

Triple Combination Therapy (ARNI, SGLT2i, MRA) in Advanced HFpEF

Who this might be right for
HFpEFLVDDMyocardial Fibrosis
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation 50
Post-approval studies (Phase 4)Study completedNCT06825156
What this trial is testing

Metabolic and Renal Outcomes in Cardiac Surgery Patients Receiving SGLT2 Inhibitors

Who this might be right for
Acute Kidney Injury
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT06111768
What this trial is testing

Sodium-Glucose Cotransporter-2 Inhibitor for Acute Cardiorenal Syndrome: A Feasibility Study

Who this might be right for
Cardiorenal Syndrome
Yale University 30
Large-scale testing (Phase 3)Study completedNCT04350593
What this trial is testing

Dapagliflozin in Respiratory Failure in Patients With COVID-19

Who this might be right for
COVID-19
Saint Luke's Health System 1,250
Testing effectiveness (Phase 2)WithdrawnNCT05058859
What this trial is testing

Long Term Clinical Efficacy of Sodium-glucose Cotransporter-2 (SGLT-2) Inhibitor in Cystinurics

Who this might be right for
Cystinuria
University of California, San Francisco
Not applicableActive Not RecruitingNCT07198191
What this trial is testing

SGLT2 Inhibitor Use After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Nationwide Cohort Study

Who this might be right for
Acute Myocardial Infarction (AMI)Type 2 Diabetes Mellitus (T2DM)
Yonsei University 200,000
Testing effectiveness (Phase 2)Looking for participantsNCT05757791
What this trial is testing

Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2) in Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive Disorder
NYU Langone Health 16
Not applicableStudy completedNCT02500186
What this trial is testing

The Clinical Study to Assess the Effect of the Amount of Carbohydrate Intake and Meals Differing in Glycemic Index (GI) in Patients Treated With a Sodium-dependent Glucose Cotransporter 2 (SGLT2) Inhibitor

Who this might be right for
Diabetes Melltius, Type 2
Kansai Electric Power Hospital 24
Post-approval studies (Phase 4)Study completedNCT02700334
What this trial is testing

Effect of Dapagliflozin on Insulin Secretion and Insulin Sensitivity in Patients With Prediabetes

Who this might be right for
PrediabetesImpaired Fasting GlucoseImpaired Glucose Tolerance
University of Guadalajara 24
Large-scale testing (Phase 3)UnknownNCT05310916
What this trial is testing

Effect of SGLT2i on Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients

Who this might be right for
Diabetic Retinopathy
Nidae Alaa 60
Post-approval studies (Phase 4)Active Not RecruitingNCT06171802
What this trial is testing

EMPagliflozin After Aortic Valve Replacement

Who this might be right for
Aortic Valve Stenosis
Rigshospitalet, Denmark 205
Not applicableStudy completedNCT03473262
What this trial is testing

Empagliflozin-based Quadruple Combination vs Insulin Glarine-based Combination Therapy in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Chungbuk National University Hospital 200
Not applicableStudy completedNCT07269197
What this trial is testing

Association of SGLT2 Inhibitors Therapy With Elastographic and Molecular Markers of Liver Injury in Type 2 Diabetes

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2
Josip Juraj Strossmayer University of Osijek 67
Large-scale testing (Phase 3)Study completedNCT05676684
What this trial is testing

Dapagliflozin With or Without Spironolactone for HFpEF

Who this might be right for
Heart Failure With Preserved Ejection Fraction
Universidade do Porto 108
Load More Results